In the finite time Deborah Addo has at the helm of the health system, she's striving to leave her mark while paving the way ...

ClinicalWorks ®, the largest ambulatory cloud EHR, today announced that InterMed, Maine's largest independent, physician-owned practice, reported an average 31% increase in daily online payments ...

CR tested 58 dog foods from brands including Blue Buffalo, Hill’s Science Diet, and Purina for key nutrients and dangerous ...

Flowfinity, a leading process management platform, has been working with engineers and consultants to address the challenges they face collecting and managing technical project data to streamline ...

El Paso names 4 deputy city managers; EPCC president gets raise; County Buildings Receive Energy Efficiency Upgrades; ...

The Pittsburgh Penguins have acquired the New York Rangers’ 2025 first-round draft pick (conditional), forward Danton Heinen, defenseman Vincent Desharnais, as well as 2024 third-round draft pick ...

From Dec. 30, 2024, through Jan. 31, the NHL is announcing the first and second quarter-century teams for each franchise that's existed since 2000, as voted by a panel of media, retired players ...

The Royals signed Carlos Estevez to provide potential ninth-inning competition for Lucas Erceg. (January 30) Ryan Pressly waived his no-trade clause and will be traded to the Cubs, where he will ...

high maintenance and perhaps not the ideal teammate, so the Dolphins sent him to the Chicago Bears for two third-round selections. Marshall would go on to play for three other teams, making it six ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

This difference underscores the need for enhanced training, pilot programs, and cross-functional teams to align priorities and ensure effective AI integration across organizational levels. The ...

Credit: Chinnapong/Shutterstock. The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen’s Leqembi (lecanemab-irmb) for maintenance ...